Table 7.
Different answers to the knowledge of asthma between intervention group and control group
| |
Intervention |
Control |
P value |
|---|---|---|---|
| group(n = 49) | group(n = 61) | ||
| Basic pathology of asthma |
|
|
0.000 |
| Bronchial hyper-responsiveness |
14.1% |
29.5% |
|
| Chronic inflammation |
75.7% |
57.2% |
|
| Allergic disease |
10.2% |
13.3% |
|
| The prevalence of asthma in China |
|
|
NS |
| Average of reported prevalence |
7.3% |
7.3% |
|
| Range of reported prevalence |
0.5–35.0% |
0.5–20.0% |
|
| Declared familiarity with asthma guidelines |
0.000 |
||
| Not familiar with any |
5.8% |
16.3% |
|
| International guidelines, GINA |
38.6% |
22.5% |
|
| Chinese guidelines |
75.6% |
51.2% |
|
| Other guidelines |
22.1% |
9.8% |
|
| Knowledge for grading severity |
0.049 |
||
| Well |
44.9% |
29.5% |
|
| Moderately |
14.3% |
24.6% |
|
| Poor |
26.5% |
23.0% |
|
| First-line prescribed medicine for mild asthma |
0.005 |
||
| Combined beta2-agonists with corticosteroid |
44.3% |
34.7% |
|
| Beta2-agonists bronchodilators |
14.8% |
34.7% |
|
| Inhaled corticosteroids |
27.9% |
26.5% |
|
| Oral corticosteroids |
6.6% |
0.0% |
|
| Leukotriene modifiers |
4.9% |
0.0% |
|
| Are you using PEFM for follow up of your asthma patient? |
NS |
||
| Yes |
63.3% |
60.7% |
|
| No |
8.2% |
19.7% |
|
| Depends on the patients’ condition |
28.6% |
19.7% |
|
| Are you satisfied with the symptom control of your patients? |
NS |
||
| Satisfied |
10.2% |
4.9% |
|
| Basically satisfied |
85.7% |
85.2% |
|
| Dissatisfied |
4.1% |
9.8% |
|
| Do you use specific immunotherapy for allergic asthma? |
0.009 |
||
| Never |
40.9% |
59.0% |
|
| Sometimes |
46.9% |
41.0% |
|
| Always |
12.2% |
0.0% |
|
| What’s the percent of patients who will fully follow your prescription? |
NS |
||
| 91–100% |
4.1% |
4.9% |
|
| 50–90% |
75.5% |
65.6% |
|
| 10–49% |
20.4% |
26.2% |
|
| <10% |
0.0% |
3.3% |
|
| What do you think are the major reasons for the lack of adherence among patients? |
NS |
||
| Side effects related to therapy |
16.3% |
23.0% |
|
| Unawareness of the benefits for pharmacotherapy |
44.9% |
47.5% |
|
| Inconvenience |
6.1% |
11.5% |
|
| Cost for pharmacotherapy |
18.4% |
6.6% |
|
| Incorrect use of inhalation device |
8.2% |
11.5% |
|
| Do you think such training course for clinicians is useful? |
NS |
||
| Very useful |
100.0% |
98.4% |
|
| Maybe useful |
0.0% |
1.6% |
|
| Not necessary |
0.0% |
0.0% |
|
| Do you think patient education is necessary? |
NS |
||
| Quite necessary |
100.0% |
100.0% |
|
| Necessary |
0.0% |
0.0% |
|
| Not necessary | 0.0% | 0.0% | |